Neurodevelopment in children with intrauterine growth restriction: adverse effects and interventions

J Matern Fetal Neonatal Med. 2016;29(4):660-8. doi: 10.3109/14767058.2015.1015417. Epub 2015 Mar 23.

Abstract

Intrauterine growth restriction (IUGR) is associated with higher rates of fetal, perinatal, and neonatal morbidity and mortality. The consequences of IUGR include short-term metabolic, hematological and thermal disturbances that lead to metabolic syndrome in children and adults. Additionally, IUGR severely affects short- and long-term fetal brain development and brain function (including motor, cognitive and executive function) and neurobehavior, especially neuropsychology. This review details the adverse effects of IUGR on fetal brain development and discusses intervention strategies.

Keywords: Adverse effects; interventions; intrauterine growth restriction; neurodevelopment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Antioxidants / therapeutic use
  • Brain / embryology
  • Brain / metabolism
  • Cerebral Palsy / etiology
  • Child
  • Cognition Disorders / etiology
  • Cognition Disorders / rehabilitation
  • Depression / etiology
  • Developmental Disabilities / etiology*
  • Female
  • Fetal Growth Retardation*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Learning Disabilities / etiology
  • Learning Disabilities / rehabilitation
  • Melatonin / therapeutic use
  • Postnatal Care
  • Pregnancy
  • Prenatal Care
  • Prenatal Exposure Delayed Effects*
  • Taurine / therapeutic use

Substances

  • Antioxidants
  • Taurine
  • Melatonin